BRAINTREE, Mass., Sept. 17, 2019 /PRNewswire/ -- Haemonetics Corporation (NYSE:HAE) announced that the Company intends to publish second quarter fiscal year 2020 financial results at 6:00 am EDT on Friday, November 1, 2019. The Company will hold a conference call with investors and analysts to discuss results and answer questions at 8:00 am EDT on November 1, 2019.
The call can be accessed with the following information:
U.S. / Canada toll free (877) 848-8880; International (716) 335-9512
Conference ID required for access: 9166003
A live webcast of the call can be accessed on Haemonetics' investor relations website. Webcast Link: https://edge.media-server.com/mmc/p/upf9m2nz
Webcast replay will be available from November 1, 2019 after 11:00 am EDT.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for customers to help them improve patient care and reduce the cost of healthcare. Our technologies address important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, visit www.haemonetics.com.
Gerry Gould, VP-Investor Relations
Olga Vlasova, Sr. Mgr.-Investor Relations
SOURCE Haemonetics Corporation